Penn Bioinvestor's  Instablog

Penn Bioinvestor
Send Message
I have extensive knowledge on drug discovery, also I am interested in fundamental analysis of biotech/pharma stocks. See Seeking Alpha's policy on anonymous authors:
  • BMY to acquire MEDX 0 comments
    Jul 22, 2009 10:44 PM | about stocks: MEDX, BMY

    Biotech has a wave of rally going on after a pleasant surprise from HGSI on its phase III clinical trial on Lupus drug. Today in after hour, news was out that BMY will buy MEDX, a long term partner, for $16/share (MEDX closed the day at $8.4/share). This will for sure spur another round of speculative rally.

    Bristol-Myers Squibb to Acquire Medarex

    • Positions Bristol-Myers Squibb for Long-Term Leadership in Biologics
    • Acquires Proven Antibody Discovery Technology
    • Gains Full Rights to Promising Phase III Compound, Ipilimumab
    • Significantly Expands Oncology and Immunology Pipeline

    NEW YORK & PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Medarex, Inc. (NASDAQ: MEDX) announced today that the companies have signed a definitive merger agreement providing for the acquisition of Medarex by Bristol-Myers Squibb, for $16.00 per share in cash. The transaction, with an aggregate purchase price of approximately $2.4 billion, has been unanimously approved by the boards of directors of both companies. Medarex’s projected $300 million in net cash and marketable securities at closing would be an asset acquired by Bristol-Myers Squibb resulting in an implied purchase price of approximately $2.1 billion.

    Stocks: MEDX, BMY
Back To Penn Bioinvestor's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.